Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of person-hours required for proton beam therapy for pediatric tumors.
Mizumoto M, Fukushima H, Miyamoto T, Oshiro Y, Sumiya T, Iizumi T, Saito T, Makishima H, Numajiri H, Hosaka S, Nagatomo K, Yamaki Y, Nakai K, Sakurai H. Mizumoto M, et al. Among authors: yamaki y. J Radiat Res. 2023 May 25;64(3):599-601. doi: 10.1093/jrr/rrad022. J Radiat Res. 2023. PMID: 37134315 Free PMC article.
Genotyping NUDT15 can predict the dose reduction of 6-MP for children with acute lymphoblastic leukemia especially at a preschool age.
Suzuki H, Fukushima H, Suzuki R, Hosaka S, Yamaki Y, Kobayashi C, Sakai A, Imagawa K, Iwabuchi A, Yoshimi A, Nakao T, Kato K, Tsuchida M, Kiyokawa N, Koike K, Noguchi E, Fukushima T, Sumazaki R. Suzuki H, et al. Among authors: yamaki y. J Hum Genet. 2016 Sep;61(9):797-801. doi: 10.1038/jhg.2016.55. Epub 2016 May 19. J Hum Genet. 2016. PMID: 27193222
Interinstitutional patient transfers between rapid chemotherapy cycles were feasible to utilize proton beam therapy for pediatric Ewing sarcoma family of tumors.
Nakao T, Fukushima H, Fukushima T, Suzuki R, Hosaka S, Yamaki Y, Kobayashi C, Iwabuchi A, Imagawa K, Sakai A, Shinkai T, Masumoto K, Sakashita S, Masumoto T, Mizumoto M, Sumazaki R, Sakurai H. Nakao T, et al. Among authors: yamaki y. Rep Pract Oncol Radiother. 2018 Sep-Oct;23(5):442-450. doi: 10.1016/j.rpor.2018.08.006. Epub 2018 Sep 5. Rep Pract Oncol Radiother. 2018. PMID: 30197580 Free PMC article.
Patient Transfer to Receive Proton Beam Therapy During Intensive Multimodal Therapy is Safe and Feasible for Patients With Newly Diagnosed High-risk Neuroblastoma.
Hosaka S, Fukushima H, Nakao T, Suzuki R, Yamaki Y, Tanaka K, Saito T, Mizumoto M, Sakurai H, Fukushima T, Takada H. Hosaka S, et al. Among authors: yamaki y. J Pediatr Hematol Oncol. 2020 Jan;42(1):e18-e24. doi: 10.1097/MPH.0000000000001570. J Pediatr Hematol Oncol. 2020. PMID: 31449498 Clinical Trial.
Urgent Proton Beam Therapy With Interinstitutional Transfer for Patients With Intracranial Rhabdomyosarcoma: Report of 3 Cases.
Inaba M, Nakao T, Hosaka S, Suzuki R, Fukushima H, Yamaki Y, Saito T, Sakashita S, Noguchi M, Minami M, Masumoto T, Mizumoto M, Sakurai H, Fukushima T, Takada H. Inaba M, et al. Among authors: yamaki y. J Pediatr Hematol Oncol. 2020 Jan;42(1):e12-e17. doi: 10.1097/MPH.0000000000001620. J Pediatr Hematol Oncol. 2020. PMID: 31688631
A case of fetal-onset type 3 familial hemophagocytic lymphohistiocytosis surviving without severe complications after early diagnosis and treatment.
Matsumoto T, Fukushima H, Fujiyama S, Nagatomo K, Hosaka S, Suzuki R, Yamaki Y, Kanai Y, Shibata H, Yasumi T, Isshiki K, Kato M, Miyazono Y, Takada H. Matsumoto T, et al. Among authors: yamaki y. Pediatr Blood Cancer. 2021 Jul;68(7):e29016. doi: 10.1002/pbc.29016. Epub 2021 Mar 26. Pediatr Blood Cancer. 2021. PMID: 33769695 No abstract available.
75 results